GDC-6036
|
GDC6036
|
2417987-45-0
|
ARV-766
|
4-(4-((1-(4-((反式-3-(4-氰基-3-甲氧基苯氧基)-2,2,4,4-四甲基環(huán)丁基)氨基甲Chemicalbook酰基)苯基)哌啶-4-基)甲基)哌嗪-1-基)-N-((S)-2,6-二氧代嘧啶-3-基)-2-氟苯甲酰胺
|
2750830-09-0
|
N-[2-methoxy-5-(trifluoromethyl)phenyl]acetamide
|
N-(2-甲氧基-5-(三氟甲基)苯基)乙酰胺
|
40622-64-8
|
Resorcinolnaphthalein
|
Resorcinolnaphthalein
|
41307-63-5
|
SAR407899
|
6-(4-哌啶基氧基)-1(2H)-異喹啉酮
|
923359-38-0
|
MJN110
|
2,5-二氧吡咯烷-1-基4-(雙(4-氯苯基)甲基)哌嗪-1-羧酸酯
|
1438416-21-7
|
C-DIM 12
|
C-DIM12
|
178946-89-9
|
INS3-54A18
|
3-(4-氯亞芐基)-1-(4-羥苯基)-5-苯基-1H-吡咯-2(3H)-酮
|
328998-53-4
|
ASP7663
|
ASP 7663;ASP-7663;ASP7663
|
1190217-35-6
|
SULFATE-IONOPHORE I
|
1,1'-(1,3-亞苯基雙(亞甲基))雙(3-苯
|
37042-63-0
|
Selexipag Impurity
|
Acetamide, 2-[4-[(5,6-diphenyl-2-pyrazinyl)(1-methylethyl)amino]butoxy]-
|
475086-28-3
|
LeterMovir-008-R
|
萊特莫韋雜質(zhì)
|
917389-34-5
|
1H-Cyclopropa[3,4]cyclopenta[1,2-c]pyrazole-1-acetic acid, 5,5-difluoro-3b,4,4a,5-tetrahydro-3-(trifluoromethyl)-, (3bR,4aS)-
|
2-((3bR,4aS)-5,5-二氟-3-(三氟甲基)-3b,4,4a,5-四氫-1H-環(huán)丙烷[3,4]環(huán)戊[1,2-c]吡唑-1 -基)乙酸
|
2189680-65-5
|
LeterMovir-013
|
萊特莫韋雜質(zhì)
|
917389-37-8
|
CNX-1351
|
CNX1351
|
1276105-89-5
|
Hepln-13
|
2-(4-溴苯基)-2,3-二氫-1H-呸啶
|
64369-13-7
|
2-Propenoic acid, 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-, methyl ester, (2E)-
|
萊特莫韋雜質(zhì)
|
1791412-04-8
|
1-(2-(3-formyl-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate
|
1-(2-(3-甲?;?N-甲基苯甲酰氨基)乙基)哌啶-4-基[1,1'-聯(lián)苯]-2-基氨基甲酸酯
|
864760-28-1
|
UniPR1331
|
UniPR1331
|
1809170-59-9
|
PIP-199
|
PIP-199
|
622795-76-0
|
dTRIM24
|
dTRIM24
|
2170695-14-2
|
NS 398
|
N-[2-(環(huán)己氧基)-4-硝基苯基]甲基磺酰胺
|
123653-11-2
|
1H-Indole, 5-bromo-3-[3-[[(1,1-dimethylethyl)diphenylsilyl]oxy]-2,2-dimethylpropyl]-2-iodo-
|
5-溴-3-(3-((叔丁基二苯基甲硅烷基)氧基)-2,2-二甲基丙基)-2-碘-1H-吲哚
|
2641451-43-4
|
raf kinase-IN-1
|
5-氯-3-(3,5-二溴-4-羥基亞芐基)吲哚啉-2-酮
|
220904-99-4
|
CGP-53716
|
N-(4-甲基-3-((4-(吡啶-3-基)嘧啶-2-基)氨基)苯基)苯甲酰胺
|
152459-94-4
|
ST034307
|
6-氯-2-(三氯甲基)-4H-苯并吡喃-4-酮
|
133406-29-8
|
R-10015
|
2-(1-(5-氯-7H-吡咯并[2,3-D]嘧啶-4-基)哌啶-4-基)-1H-苯并[D]咪唑-6-羧酸甲酯
|
2097938-51-5
|
BM635
|
BM635
|
1493762-74-5
|
9H-Purin-2-amine, 6-chloro-9-[(2R)-2-deoxy-2-fluoro-2-methyl-β-D-erythro-pentofuranosyl]-
|
|
881881-89-6
|
TH-Z93
|
化合物TH-Z93
|
2260887-09-8
|
917389-35-6
|
來特莫韋雜質(zhì)
|
917389-35-6
|
Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2S,3S)-, compd. with methyl (4S)-8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-4-quinazolineacetate (1:1)
|
萊特莫韋雜質(zhì)
|
917389-30-1
|
NITD-349
|
N-(4,4-二甲基環(huán)己基)-4,6-二氟-1H-吲哚-2-甲酰胺
|
1473450-62-2
|
M-31850
|
化合物M-31850
|
281224-40-6
|
BOS318
|
化合物BOS-318
|
2387633-15-8
|
UPF1069
|
5-(2-氧代-2-苯基乙氧基)-1(2H)-異喹啉酮
|
1048371-03-4
|
Tricyclo[3.3.1.13,7]decan-1-aMine, 3,5,7-triMethyl-, hydrochloride
|
1,3,5-三甲基金剛烷胺鹽酸鹽
|
15210-60-3
|
Urea, N-(2-broMo-6-fluorophenyl)-N'-[2-Methoxy-5-(trifluoroMethyl)phenyl]-
|
萊特莫韋雜質(zhì)
|
917389-23-2
|
VK-II-36
|
化合物VK-II-43
|
955371-66-1
|
Upadacitinib Impurity
|
烏帕替尼雜質(zhì)
|
1201187-46-3
|
FQ
|
4(1H)-Quinazolinone, 2-(4-fluorophenyl)-
|
190838-76-7
|
CB-7921220
|
6-(4-氨基苯乙烯基)吡啶-2-羧酸
|
115453-99-1
|
Letermovir Impurity
|
1,3-雙(2-甲氧基-5-(三氟甲基)苯基)脲
|
6064-14-8
|
CA-4948
|
CA-4948
|
1801343-74-7
|
Alrestatin
|
阿瑞司他丁
|
51411-04-2
|
EB-3D
|
1,1'-(((乙烷-1,2-二基雙(氧基))雙(4,1-亞苯基))雙(亞甲基))雙(4-(二甲氨基)吡啶-1-鎓)溴化物
|
1839150-63-8
|
ML67-33
|
ML67-33
|
1443290-89-8
|
BMS-P5
|
BMS-P5
|
1550371-22-6
|
Atopaxar Hydrobromide
|
2-(5,6-二乙氧基-7-氟-1,3-二氫-1-亞氨基-2H-異吲哚-2-基)-1-[3-叔丁基-4-甲氧基-5-(4-嗎啉基)苯基]乙酮
|
751475-53-3
|
2-(2,6-dichloro-3,5-dimethoxyphenyl)acetonitrile
|
2-(2,6-二氯-3,5-二甲氧基苯基)乙腈
|
869882-16-6
|
Difluorinated Curcumin
|
CDF
|
1170354-22-9
|
ML402
|
298684-44-3
|
298684-44-3
|
VH032
|
VH-032
|
1448188-62-2
|
AF40431
|
AF40431
|
181125-92-8
|
TD-106
|
TD-106
|
2250288-69-6
|
BM212
|
1-((1,5-二(4-氯苯基)-2-甲基-1H-吡咯-3-基)甲基)-4-甲基哌嗪
|
146204-42-4
|
NE-100 hydrochloride
|
N,N-二乙基-2-(4-甲氧基-3-苯乙基氧基苯基)乙胺鹽酸鹽
|
149409-57-4
|
ST1237
|
|
1380593-17-8
|
Eprotirome
|
3-((3,5-二溴-4-(4-羥基-3-異丙基苯氧基)苯基)氨基)-3-氧代丙酸
|
355129-15-6
|
Etomidate EP Impurity A
|
依托咪酯雜質(zhì)A
|
3157-27-5
|
N-Acetyl DeMethyl MeMantine
|
778-09-6
|
(R)-Metomidate
|
依托咪酯雜質(zhì)
|
61045-91-8
|
7-Acetamido-1,3,5-trimethyladamantane
|
3,5,7-三甲基-1-金剛烷乙酰胺
|
15210-64-7
|
Gsk484 hydrochloride
|
CS-2265
|
1652591-81-5
|
MSDC-0602
|
5-(4-(2-(3-甲氧基苯基)-2-氧代乙氧基)芐基)噻唑烷-2,4-二酮
|
1133819-87-0
|
KY1220
|
5-((1-(4-硝基苯基)-1H-吡咯-2-基)亞甲基)-2-硫代咪唑烷-4-酮
|
292168-79-7
|
NAcM-OPT
|
化合物NACM-OPT
|
2089293-61-6
|
THAL-SNS-032
|
THAL-SNS-032
|
2139287-33-3
|
Y06036
|
5-溴-2-甲氧基-N-(6-甲氧基-3-甲基苯并[d]異惡唑-5-基)苯磺酰胺
|
1832671-96-1
|
Loreclezole
|
(Z)-1-(2-氯-2-(2,4-二氯苯基)乙烯基)-1H-1,2,4-三唑
|
117857-45-1
|
INDEX NAME NOT YET ASSIGNED
|
|
2761681-01-8
|
Letomovir Impurity 13
|
來特莫韋雜質(zhì)13
|
2991059-69-7
|
BI-2865
|
(4S)-2-氨基-4,5,6,7-四氫-4-甲基-4-[3-[4-[(1S)-1-[(2S)-1-甲基-2-吡咯烷基]乙氧基]-2-嘧啶基]-1,2,4-惡二唑-5-基]苯并[b]噻吩-3-甲腈
|
2937327-93-8
|
4-Quinazolineacetic acid, 8-fluoro-3,4-dihydro-2-[4-(3-methoxyphenyl)-4-oxido-1-piperazinyl]-3-[2-methoxy-5-(trifluoromethyl)phenyl]-, (4S)-
|
來特莫韋雜質(zhì)
|
2991059-71-1
|
ethyl (2R,3R)-3-cyclopropyl-1-methylaziridine-2-carboxylate
|
|
2864383-32-2
|
Picotamide
|
吡考胺
|
32828-81-2
|
Nomifensine maleate
|
諾米芬新馬來酸鹽
|
32795-47-4
|
(S)-Remoxipride Hydrochloride
|
瑞莫必利鹽酸鹽
|
73220-03-8
|
Laninamivir
|
拉尼米韋
|
203120-17-6
|
Auten-99 HBr
|
2-([1,1'-聯(lián)苯]-4-基)-5,6-二氫咪唑并[2,1-b]噻唑氫溴酸鹽
|
1049780-58-6
|
Cariprazine Impurity
|
卡利拉嗪雜質(zhì)6
|
1231947-89-9
|
DBRD9
|
DBRD9
|
2170679-45-3
|
SSAA09E1
|
SSAA09E1
|
433212-75-0
|
GSK215
|
GSK215
|
2743427-26-9
|
2-Propenamide, N-(2-bromo-6-fluorophenyl)-
|
來特莫韋雜質(zhì)
|
1695869-28-3
|
Methyl (αS,2S)-4-[(1,1-dimethylethoxy)carbonyl]-α-[[(phenylmethoxy)carbonyl]amino]-2-morpholinepropanoate
|
(S)-3-[(S)-4-Boc-嗎啉-2-基]-2-(Cbz-氨基)丙酸甲酯
|
2641824-60-2
|
Demethyl Memantine Hydrochloride
|
1-氨基-3-甲基金剛烷鹽酸鹽
|
33103-93-4
|
2-Propenoic acid, 3-(2-amino-3-fluorophenyl)-, methyl ester, (2E)-
|
來特莫韋雜質(zhì)
|
690664-20-1
|
Letermovir Impurity
|
917389-29-8
|
917389-29-8
|
AU1235
|
1338780-86-1
|
1338780-86-1
|
ASTX660
|
ASTX660
|
1799328-86-1
|
C-215
|
N-[(2,4-dichlorophenyl)methyl]-1-propylbenzimidazol-5-amine
|
912780-51-9
|
2-Pyrazinecarbonitrile, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-
|
吉列替尼N-1
|
2043019-99-2
|
RBM013209
|
RBN013209
|
2597933-17-8
|
FK-3311
|
N-[4-乙?;?2-(2,4-二氟苯氧基)苯基]-甲烷磺酰胺
|
116686-15-8
|
A 438079 hydrochloride
|
3-[[5-(2,3-二氯苯基)-1H-四唑-1-基]甲基]吡啶單鹽酸鹽
|
899431-18-6
|
Benzoic acid, 2-hydroxy-, compd. with (2E)-methyl 3-[3-fluoro-2-[[[4-(3-methoxyphenyl)-1-piperazinyl][[2-methoxy-5-(trifluoromethyl)phenyl]imino]methyl]amino]phenyl]-2-propenoate (1:1)
|
/
|
1791412-05-9
|
NSC 756093
|
NSC 756093
|
1629908-92-4
|
SCH529074
|
SCH 529074
|
922150-11-6
|
RN-18
|
431980-38-0
|
431980-38-0
|
GSK3359088
|
GSK 3359088
|
1628830-21-6
|
VB-124
|
VB-124
|
2230186-18-0
|